Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Galloway

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pediatric Clinics of North America|June 3, 2000
Pain and symptom control in terminally ill childrenK S Galloway, M Yaster
Journal of Back and Musculoskeletal Rehabilitation|February 28, 2014
Pain management for special populations-pediatric, geriatric, and intensive care unit patientsP S Staats, K S Galloway
Pediatric Clinics of North America|June 3, 2000
Pediatric acute pain managementB Golianu, E J Krane, K S Galloway, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1982
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compoundsK O Smith, K S Galloway, K K Ogilvie, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1982
A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2K O Smith, K S Galloway, W L Kennell, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1984
Experimental ocular herpetic infections in rabbits. Treatment with 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanineK O Smith, S L Hodges, W L Kennell, et al.
American Journal of Veterinary Research|June 1, 1983
Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanineK O Smith, K S Galloway, S L Hodges, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pediatric Clinics of North America|June 3, 2000
Pain and symptom control in terminally ill childrenK S Galloway, M Yaster
Journal of Back and Musculoskeletal Rehabilitation|February 28, 2014
Pain management for special populations-pediatric, geriatric, and intensive care unit patientsP S Staats, K S Galloway
Pediatric Clinics of North America|June 3, 2000
Pediatric acute pain managementB Golianu, E J Krane, K S Galloway, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1982
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compoundsK O Smith, K S Galloway, K K Ogilvie, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1982
A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2K O Smith, K S Galloway, W L Kennell, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1984
Experimental ocular herpetic infections in rabbits. Treatment with 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanineK O Smith, S L Hodges, W L Kennell, et al.
American Journal of Veterinary Research|June 1, 1983
Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanineK O Smith, K S Galloway, S L Hodges, et al.
Pageof 1